Literature DB >> 20981813

Distal extremity pain as a presenting feature of Fabry's disease.

Ilaria Pagnini1, Walter Borsini, Franco Cecchi, Aurelio Sgalambro, Iacopo Olivotto, Anna Frullini, Rolando Cimaz.   

Abstract

OBJECTIVE: Fabry's disease (FD) is an X-linked lysosomal storage disease. Distal extremity pain can be an early finding and renal, cardiac, and cerebrovascular complications may lead to complications and mortality. Treatment is now available for these patients, who may not be diagnosed correctly for years if the neuropathic nature of the pain is not recognized. The aim of our study was to describe early clinical features in a cohort of patients with FD and to emphasize the importance of distal extremity pain for early diagnosis.
METHODS: The medical charts of 35 patients with FD followed in a single center were reviewed. When data were incomplete, a detailed pain questionnaire was sent to patients. Nonresponders were contacted by telephone.
RESULTS: Distal extremity pain was present in the majority of cases (25 of 35). The mean age at diagnosis of FD was 43.5 years (range 5-77 years). Distal extremity pain was more prevalent in males than females and occurred mostly in childhood or adolescence. When present at onset, the disease progressed with subsequent organ system involvement. Misdiagnoses were frequent and included growing pains, juvenile idiopathic arthritis, connective tissue disease, and gout.
CONCLUSION: Clinical manifestations of FD, including episodes of severe pain in the feet and hands, often start in childhood. Distal extremity pain may be the only symptom for a considerable period of time. Patients may be wrongly labeled as having rheumatologic conditions, resulting in long diagnostic and therapeutic delays. Rheumatologists should be aware of the clinical aspects of FD and include it in the differential diagnosis of distal extremity pain in childhood and adolescence.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2010        PMID: 20981813     DOI: 10.1002/acr.20385

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  7 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

2.  When arthralgia is not arthritis.

Authors:  Juan Politei; Graciela Remondino; Ricardo Heguilen; Eric Wallace; Consuelo Durand; Andrea Schenone
Journal:  Eur J Rheumatol       Date:  2016-04-05

Review 3.  Pain management strategies for neuropathic pain in Fabry disease--a systematic review.

Authors:  Y Schuller; G E Linthorst; C E M Hollak; I N Van Schaik; M Biegstraaten
Journal:  BMC Neurol       Date:  2016-02-24       Impact factor: 2.474

4.  Genetic Screening of Mutations Associated with Fabry Disease in a Nationwide Cohort of Juvenile Idiopathic Arthritis Patients.

Authors:  Maria J Gonçalves; Ana F Mourão; António Martinho; Olívia Simões; José Melo-Gomes; Manuel Salgado; Paula Estanqueiro; Célia Ribeiro; Iva Brito; João E Fonseca; Helena Canhão
Journal:  Front Med (Lausanne)       Date:  2017-03-01

5.  Upper Extremity Compartment Syndrome in a Patient with Acute Gout Attack but without Trauma or Other Typical Causes.

Authors:  John G Skedros; James S Smith; Marshall K Henrie; Ethan D Finlinson; Joel D Trachtenberg
Journal:  Case Rep Orthop       Date:  2018-01-23

6.  Frequency of Fabry disease in a juvenile idiopathic arthritis cohort.

Authors:  Luciana Paim-Marques; Amanda Virginia Cavalcante; Islane Verçosa; Paula Carneiro; Marcia Souto-Maior; Erlane Marques; Simone Appenzeller
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-12       Impact factor: 3.054

7.  Significant improvement in Fabry disease podocytopathy after 3 years of treatment with agalsidase beta.

Authors:  Shuichi Ito; Masao Ogura; Koichi Kamei; Kentaro Matsuoka; David G Warnock
Journal:  Pediatr Nephrol       Date:  2016-04-29       Impact factor: 3.651

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.